Skip to content
Search

Latest Stories

India proposes ban on e-cigarettes, with jail terms for offenders

INDIA'S health ministry has proposed a ban on the production and import of electronic cigarettes, documents showed, potentially jeopardizing the expansion plans of big firms like Juul Labs and Philip Morris International.

The ministry has proposed that the government issue an executive order banning the devices in the public interest, saying it was needed to ensure e-cigarettes don't become an ‘epidemic’ among children and young adults.


"E-cigarettes and similar technologies that encourage tobacco use or adversely impact public health are hazardous for an active as well as passive user," the health ministry said in an internal note that the federal cabinet is expected to consider.

Health officials are proposing jail terms of up to three years, with a penalty of up to Rs 500,000 ($7,000), for repeat offenders against the new rules, according to a draft of the executive order.

First-time offenders would face a prison term of up to one year and a fine of Rs 100,000.

Such orders are typically issued in India as an emergency measure when parliament is not in session.

It can lapse if it is not approved when lawmakers convene against in the next session, which will most likely be held around November.

It was not immediately clear whether the draft executive order will face changes, or when it will be approved.

India's health ministry did not respond to a request for comment.

The ministry's plans would deal a blow to US-based Juul Labs Inc, which is hoping to launch its e-cigarette in India and has hired several senior executives in recent months.

Philip Morris also has plans to launch its heat-not-burn smoking device in India.

Advocates for the devices say e-cigarettes are far less harmful than smoking tobacco, because users do not inhale the same dangerous matter.

But many tobacco-control activists are opposed to e-cigarettes, saying they could lead to nicotine addiction and push people to consume tobacco.

"There is evidence that these products are a gateway to tobacco products and induce adolescents and young adults to nicotine use leading to addiction," the health ministry said in the document.

India has 106 million adult smokers, second only to China in the world, making it a lucrative market for firms such as Juul and Philip Morris. More than 900,000 people die each year in the country due to tobacco-related illnesses.

Sixteen state governments in India have prohibited e-cigarettes but there is as yet no federal legislation to deal with what the health ministry termed the "hazardous product".

Justifying its call for a ban, the health ministry argued that e-cigarettes can also be used as delivery devices for other substances such as cannabis, and could promote dual use with conventional cigarettes.

"These devices are injurious to health and proliferation of these products has a negative impact on public health," the draft said.

The health ministry had called for Juul's entry into India to be blocked, saying such products were "addictive and could potentially undermine our tobacco control efforts".

Juul, whose sleek vaping devices that resemble USB flash drives have become a sensation in the US, has previously said it aims to improve the lives of smokers by offering a "satisfying alternative to combustible cigarettes".

(Reuters)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less